APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atazanavir

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Atazanavir Industry Growth and Trends Forecast to 2032

20 December 202597 pages

Choose your research edition.

Industry ResearchAtazanavir Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Atazanavir Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Atazanavir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atazanavir Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Atazanavir Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Atazanavir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Atazanavir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Atazanavir is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Atazanavir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Atazanavir include TEVA, Mylan, Emcure, Cipla, Bristol-Myers Squibb and Aurobindo Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Atazanavir market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Atazanavir market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Atazanavir market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Atazanavir.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Atazanavir market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Atazanavir Market by Company

TEVA

Mylan

Emcure

Cipla

Bristol-Myers Squibb

Aurobindo Pharma

Atazanavir Segment by Type

50 mg Oral Powder

300 mg Capsule

200 mg Capsule

150 mg Capsule

Atazanavir Segment by Application

Adults

Children 3 months of age and older

Atazanavir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atazanavir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atazanavir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atazanavir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Atazanavir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Atazanavir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50 mg Oral Powder Table 2. Major Company of 300 mg Capsule Table 3. Major Company of 200 mg Capsule Table 4. Major Company of 150 mg Capsule Table 5. Global Atazanavir Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Atazanavir Sales by Type (2021-2026) & (W Units) Table 7. Global Atazanavir Sales Market Share in Volume by Type (2021-2026) Table 8. Global Atazanavir Sales by Type (2021-2026) & (US$ Million) Table 9. Global Atazanavir Sales Market Share in Value by Type (2021-2026) Table 10. Global Atazanavir Price by Type (2021-2026) & (US$/Unit) Table 11. Global Atazanavir Sales by Type (2027-2032) & (W Units) Table 12. Global Atazanavir Sales Market Share in Volume by Type (2027-2032) Table 13. Global Atazanavir Sales by Type (2027-2032) & (US$ Million) Table 14. Global Atazanavir Sales Market Share in Value by Type (2027-2032) Table 15. Global Atazanavir Price by Type (2027-2032) & (US$/Unit) Table 16. North America Atazanavir Sales by Type (2021-2026) & (W Units) Table 17. North America Atazanavir Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Atazanavir Sales by Type (2021-2026) & (W Units) Table 19. Europe Atazanavir Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Atazanavir Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Atazanavir Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Atazanavir Sales by Type (2021-2026) & (W Units) Table 23. Latin America Atazanavir Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Atazanavir Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Atazanavir Sales by Type (2021-2026) & (US$ Million) Table 26. Atazanavir Industry Trends Table 27. Atazanavir Industry Drivers Table 28. Atazanavir Industry Opportunities and Challenges Table 29. Atazanavir Industry Restraints Table 30. Global Atazanavir Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Atazanavir Revenue Market Share by Company (2021-2026) Table 32. Global Atazanavir Sales by Company (2021-2026) & (W Units) Table 33. Global Atazanavir Sales Share by Company (2021-2026) Table 34. Global Atazanavir Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Atazanavir Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Atazanavir Major Company Production Sites and Headquarters Table 37. Global Atazanavir Company, Product Type & Application Table 38. Global Atazanavir Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Atazanavir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Atazanavir Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Atazanavir Sales by Region (2021-2026) & (W Units) Table 43. Global Atazanavir Sales Market Share in Volume by Region (2021-2026) Table 44. Global Atazanavir Sales by Region (2021-2026) & (US$ Million) Table 45. Global Atazanavir Sales Market Share in Value by Region (2021-2026) Table 46. Global Atazanavir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Atazanavir Sales by Region (2027-2032) & (W Units) Table 48. Global Atazanavir Sales Market Share in Volume by Region (2027-2032) Table 49. Global Atazanavir Sales by Region (2027-2032) & (US$ Million) Table 50. Global Atazanavir Sales Market Share in Value by Region (2027-2032) Table 51. Global Atazanavir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Atazanavir Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Atazanavir Sales by Application (2021-2026) & (W Units) Table 54. Global Atazanavir Sales Market Share in Volume by Application (2021-2026) Table 55. Global Atazanavir Sales by Application (2021-2026) & (US$ Million) Table 56. Global Atazanavir Sales Market Share in Value by Application (2021-2026) Table 57. Global Atazanavir Price by Application (2021-2026) & (US$/Unit) Table 58. Global Atazanavir Sales by Application (2027-2032) & (W Units) Table 59. Global Atazanavir Sales Market Share in Volume by Application (2027-2032) Table 60. Global Atazanavir Sales by Application (2027-2032) & (US$ Million) Table 61. Global Atazanavir Sales Market Share in Value by Application (2027-2032) Table 62. Global Atazanavir Price by Application (2027-2032) & (US$/Unit) Table 63. North America Atazanavir Sales by Application (2021-2026) & (W Units) Table 64. North America Atazanavir Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Atazanavir Sales by Application (2021-2026) & (W Units) Table 66. Europe Atazanavir Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Atazanavir Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Atazanavir Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Atazanavir Sales by Application (2021-2026) & (W Units) Table 70. Latin America Atazanavir Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Atazanavir Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Atazanavir Sales by Application (2021-2026) & (US$ Million) Table 73. TEVA Company Information Table 74. TEVA Business Overview Table 75. TEVA Atazanavir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. TEVA Atazanavir Product Portfolio Table 77. TEVA Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Atazanavir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Mylan Atazanavir Product Portfolio Table 82. Mylan Recent Development Table 83. Emcure Company Information Table 84. Emcure Business Overview Table 85. Emcure Atazanavir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Emcure Atazanavir Product Portfolio Table 87. Emcure Recent Development Table 88. Cipla Company Information Table 89. Cipla Business Overview Table 90. Cipla Atazanavir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Cipla Atazanavir Product Portfolio Table 92. Cipla Recent Development Table 93. Bristol-Myers Squibb Company Information Table 94. Bristol-Myers Squibb Business Overview Table 95. Bristol-Myers Squibb Atazanavir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Bristol-Myers Squibb Atazanavir Product Portfolio Table 97. Bristol-Myers Squibb Recent Development Table 98. Aurobindo Pharma Company Information Table 99. Aurobindo Pharma Business Overview Table 100. Aurobindo Pharma Atazanavir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Aurobindo Pharma Atazanavir Product Portfolio Table 102. Aurobindo Pharma Recent Development Table 103. North America Atazanavir Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 104. North America Atazanavir Sales by Country (2021-2026) & (W Units) Table 105. North America Atazanavir Sales Market Share by Country (2021-2026) Table 106. North America Atazanavir Sales Forecast by Country (2027-2032) & (W Units) Table 107. North America Atazanavir Sales Market Share Forecast by Country (2027-2032) Table 108. North America Atazanavir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Atazanavir Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Atazanavir Market Share by Country (2021-2026) Table 111. North America Atazanavir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Atazanavir Market Share Forecast by Country (2027-2032) Table 113. Europe Atazanavir Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 114. Europe Atazanavir Sales by Country (2021-2026) & (W Units) Table 115. Europe Atazanavir Sales Market Share by Country (2021-2026) Table 116. Europe Atazanavir Sales Forecast by Country (2027-2032) & (W Units) Table 117. Europe Atazanavir Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Atazanavir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Atazanavir Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Atazanavir Market Share by Country (2021-2026) Table 121. Europe Atazanavir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Atazanavir Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Atazanavir Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Atazanavir Sales by Country (2021-2026) & (W Units) Table 125. Asia-Pacific Atazanavir Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Atazanavir Sales Forecast by Country (2027-2032) & (W Units) Table 127. Asia-Pacific Atazanavir Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Atazanavir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Atazanavir Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Atazanavir Market Share by Country (2021-2026) Table 131. Asia-Pacific Atazanavir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Atazanavir Market Share Forecast by Country (2027-2032) Table 133. Latin America Atazanavir Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 134. Latin America Atazanavir Sales by Country (2021-2026) & (W Units) Table 135. Latin America Atazanavir Sales Market Share by Country (2021-2026) Table 136. Latin America Atazanavir Sales Forecast by Country (2027-2032) & (W Units) Table 137. Latin America Atazanavir Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Atazanavir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Atazanavir Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Atazanavir Market Share by Country (2021-2026) Table 141. Latin America Atazanavir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Atazanavir Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Atazanavir Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Atazanavir Sales by Country (2021-2026) & (W Units) Table 145. Middle East and Africa Atazanavir Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Atazanavir Sales Forecast by Country (2027-2032) & (W Units) Table 147. Middle East and Africa Atazanavir Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Atazanavir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Atazanavir Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Atazanavir Market Share by Country (2021-2026) Table 151. Middle East and Africa Atazanavir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Atazanavir Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Atazanavir Distributors List Table 156. Atazanavir Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Atazanavir Image Figure 2. Global Atazanavir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atazanavir Market Size (2021-2032) & (US$ Million) Figure 4. Global Atazanavir Sales (2021-2032) & (W Units) Figure 5. 50 mg Oral Powder Image Figure 6. Global 50 mg Oral Powder Sales YoY Growth (2021-2032) & (W Units) Figure 7. 300 mg Capsule Image Figure 8. Global 300 mg Capsule Sales YoY Growth (2021-2032) & (W Units) Figure 9. 200 mg Capsule Image Figure 10. Global 200 mg Capsule Sales YoY Growth (2021-2032) & (W Units) Figure 11. 150 mg Capsule Image Figure 12. Global 150 mg Capsule Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Atazanavir Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Atazanavir Market Share by Type 2025 VS 2032 Figure 15. North America Atazanavir Sales Market Share in Volume by Type in 2025 Figure 16. North America Atazanavir Sales Market Share in Value by Type in 2025 Figure 17. Europe Atazanavir Sales Market Share in Volume by Type in 2025 Figure 18. Europe Atazanavir Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Atazanavir Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Atazanavir Sales Market Share in Value by Type in 2025 Figure 21. Latin America Atazanavir Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Atazanavir Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Atazanavir Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Atazanavir Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Atazanavir Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Adults Image Figure 28. Global Adults Sales YoY Growth (2021-2032) & (W Units) Figure 29. Children 3 months of age and older Image Figure 30. Global Children 3 months of age and older Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Atazanavir Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Atazanavir Market Share by Application 2025 VS 2032 Figure 33. North America Atazanavir Sales Market Share in Volume by Application in 2025 Figure 34. North America Atazanavir Sales Market Share in Value by Application in 2025 Figure 35. Europe Atazanavir Sales Market Share in Volume by Application in 2025 Figure 36. Europe Atazanavir Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Atazanavir Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Atazanavir Sales Market Share in Value by Application in 2025 Figure 39. Latin America Atazanavir Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Atazanavir Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Atazanavir Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Atazanavir Sales Market Share in Value by Application in 2025 Figure 43. North America Atazanavir Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Atazanavir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Atazanavir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Atazanavir Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Atazanavir Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Atazanavir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Atazanavir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Atazanavir Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Atazanavir Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Atazanavir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Atazanavir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Atazanavir Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Atazanavir Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Atazanavir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Atazanavir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Atazanavir Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Atazanavir Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Atazanavir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Atazanavir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Atazanavir Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Atazanavir Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Atazanavir Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mg Oral Powder
  • 300 mg Capsule
  • 200 mg Capsule
  • 150 mg Capsule
Applications
  • Adults
  • Children 3 months of age and older
Companies covered
  • TEVA
  • Mylan
  • Emcure
  • Cipla
  • Bristol-Myers Squibb
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Atazanavir Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Atazanavir Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Atazanavir Market by Type
  6. 1.3.1 50 mg Oral Powder
  7. 1.3.2 300 mg Capsule
  8. 1.3.3 200 mg Capsule
  9. 1.3.4 150 mg Capsule
  10. 1.4 Global Atazanavir Market Size by Type
  11. 1.4.1 Global Atazanavir Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Atazanavir Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Atazanavir Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Atazanavir Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Atazanavir Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Atazanavir Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Atazanavir Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Atazanavir Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Atazanavir Industry Trends
  2. 2.2 Atazanavir Industry Drivers
  3. 2.3 Atazanavir Industry Opportunities and Challenges
  4. 2.4 Atazanavir Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Atazanavir Revenue (2021-2026)
  2. 3.2 Global Top Players by Atazanavir Sales (2021-2026)
  3. 3.3 Global Top Players by Atazanavir Price (2021-2026)
  4. 3.4 Global Atazanavir Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Atazanavir Major Company Production Sites & Headquarters
  6. 3.6 Global Atazanavir Company, Product Type & Application
  7. 3.7 Global Atazanavir Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Atazanavir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Atazanavir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Atazanavir Tier 1, Tier 2, and Tier 3
4 Atazanavir Regional Status and Outlook
  1. 4.1 Global Atazanavir Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Atazanavir Historic Market Size by Region
  3. 4.2.1 Global Atazanavir Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Atazanavir Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Atazanavir Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Atazanavir Forecasted Market Size by Region
  7. 4.3.1 Global Atazanavir Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Atazanavir Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Atazanavir Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Atazanavir by Application
  1. 5.1 Atazanavir Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children 3 months of age and older
  4. 5.2 Global Atazanavir Market Size by Application
  5. 5.2.1 Global Atazanavir Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Atazanavir Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Atazanavir Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Atazanavir Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Atazanavir Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Atazanavir Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Atazanavir Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Atazanavir Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 TEVA
  2. 6.1.1 TEVA Company Information
  3. 6.1.2 TEVA Business Overview
  4. 6.1.3 TEVA Atazanavir Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 TEVA Atazanavir Product Portfolio
  6. 6.1.5 TEVA Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Atazanavir Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Atazanavir Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 Emcure
  14. 6.3.1 Emcure Company Information
  15. 6.3.2 Emcure Business Overview
  16. 6.3.3 Emcure Atazanavir Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Emcure Atazanavir Product Portfolio
  18. 6.3.5 Emcure Recent Developments
  19. 6.4 Cipla
  20. 6.4.1 Cipla Company Information
  21. 6.4.2 Cipla Business Overview
  22. 6.4.3 Cipla Atazanavir Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Cipla Atazanavir Product Portfolio
  24. 6.4.5 Cipla Recent Developments
  25. 6.5 Bristol-Myers Squibb
  26. 6.5.1 Bristol-Myers Squibb Company Information
  27. 6.5.2 Bristol-Myers Squibb Business Overview
  28. 6.5.3 Bristol-Myers Squibb Atazanavir Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bristol-Myers Squibb Atazanavir Product Portfolio
  30. 6.5.5 Bristol-Myers Squibb Recent Developments
  31. 6.6 Aurobindo Pharma
  32. 6.6.1 Aurobindo Pharma Company Information
  33. 6.6.2 Aurobindo Pharma Business Overview
  34. 6.6.3 Aurobindo Pharma Atazanavir Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Aurobindo Pharma Atazanavir Product Portfolio
  36. 6.6.5 Aurobindo Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Atazanavir Sales by Country
  2. 7.1.1 North America Atazanavir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Atazanavir Sales by Country (2021-2026)
  4. 7.1.3 North America Atazanavir Sales Forecast by Country (2027-2032)
  5. 7.2 North America Atazanavir Market Size by Country
  6. 7.2.1 North America Atazanavir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Atazanavir Market Size by Country (2021-2026)
  8. 7.2.3 North America Atazanavir Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Atazanavir Sales by Country
  2. 8.1.1 Europe Atazanavir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Atazanavir Sales by Country (2021-2026)
  4. 8.1.3 Europe Atazanavir Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Atazanavir Market Size by Country
  6. 8.2.1 Europe Atazanavir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Atazanavir Market Size by Country (2021-2026)
  8. 8.2.3 Europe Atazanavir Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Atazanavir Sales by Country
  2. 9.1.1 Asia-Pacific Atazanavir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Atazanavir Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Atazanavir Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Atazanavir Market Size by Country
  6. 9.2.1 Asia-Pacific Atazanavir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Atazanavir Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Atazanavir Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Atazanavir Sales by Country
  2. 10.1.1 South America Atazanavir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Atazanavir Sales by Country (2021-2026)
  4. 10.1.3 South America Atazanavir Sales Forecast by Country (2027-2032)
  5. 10.2 South America Atazanavir Market Size by Country
  6. 10.2.1 South America Atazanavir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Atazanavir Market Size by Country (2021-2026)
  8. 10.2.3 South America Atazanavir Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Atazanavir Sales by Country
  2. 11.1.1 Middle East and Africa Atazanavir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Atazanavir Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Atazanavir Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Atazanavir Market Size by Country
  6. 11.2.1 Middle East and Africa Atazanavir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Atazanavir Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Atazanavir Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Atazanavir Value Chain Analysis
  2. 12.1.1 Atazanavir Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Atazanavir Production Mode & Process
  7. 12.2 Atazanavir Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Atazanavir Distributors
  10. 12.2.3 Atazanavir Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst